JAMES M. VOGEL, M.D.; HARRY R. KIMBALL, M.D.; SHELDON M. WOLFF, M.D., F.A.C.P.; SEYMOUR PERRY, M.D., F.A.C.P.
This content is PDF only. Please click on the PDF icon to access.
The administration of cytotoxic drugs for the control of neoplastic growth or immunosuppression often results in the depressed maturation of normal bone marrow elements. While drug-induced anemia and thrombocytopenia can be at least partially corrected with red cell and platelet transfusions, severe granulocytopenia and the attendant risk of bacterial and fungal infections present the greatest problem in treatment (1, 2). Leukocytes are difficult to obtain in large numbers; besides, their effectiveness has never been clearly demonstrated (3). Thus, reliable estimation of the bone marrow granulocyte mass before treatment would be a valuable adjunct to the rational use of myelosuppressive agents.
VOGEL JM, KIMBALL HR, WOLFF SM, PERRY S. Etiocholanolone in the Evaluation of Marrow Reserves in Patients Receiving Cytotoxic Agents. Ann Intern Med. 1967;67:1226–1238. doi: 10.7326/0003-4819-67-6-1226
Download citation file:
Published: Ann Intern Med. 1967;67(6):1226-1238.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use